Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2a Study Using Natural Killer (NK) Cell Therapy Combined With Hepatic Artery Infusion Chemotherapy (HAIC) in Patients With Locally Advanced Hepatocellular Carcinoma

NCT05040438 is registered in ClinicalTrials.gov with Vaxcell Bio, Co., Ltd. as lead sponsor.

NCT NCT05040438
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05040438 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2a Study Using Natural Killer (NK) Cell Therapy Combined With Hepatic Artery Infusion Chemotherapy (HAIC) in Patients With Locally Advanced Hepatocellular Carcinoma
Lead sponsor
Vaxcell Bio, Co., Ltd.
Phase
Phase 2
Overall status
Completed
Start date
October 15, 2019
Completion date
September 14, 2023
Enrollment
17 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

locally advanced hepatocellular carcinoma